Sort by
Refine Your Search
-
Category
-
Field
-
well as the characterization by mass spectrometry of the components of supramolecular complexes discovered in the laboratory that are involved in NF-κB activation. We have also demonstrated their constitutive presence in tumor
-
), Sainte Anne Hospital, Paris, France. The INM is part of the GHU Paris, Psychiatry & Neurosciences. The INM combines clinical activities and innovative clinical research in psychiatry with basic research in
-
committed to areas relating to the health of vulnerable populations, the One Health and global health approach, and the development of diagnostics, prediction strategies and innovative therapies. As part of
-
. The recruitment of a young researcher with high potential is part of this approach. The recipient will energize and bring a new dimension to the host laboratory's research project while building on a solid pre
-
that is part of the dynamic Saclay scientific hub, combining high-level research, teaching, and innovation at the cutting edge of science and technology. The research conducted covers all modern
-
animal models. Summary of the teaching project: The candidate will be involved in the training/research link by supervising doctoral students and setting up a tutoring program as part of the graduates
-
U1034 has played a leading role, particularly in the biological and mechanistic components. It thus reinforces the Unit’s position within excellent networks with strong translational potential
-
development of tailored bio-inks, enabling control over graft architecture as well as the spatial distribution of cells and bioactive signals. This program is part of a strong translational dynamic, with
-
support their professional development. Finally, the chair is part of an open and responsible science approach, prioritizing the study of human tissues and translational approaches, thereby strengthening
-
its potential impact on subsequent child development, with the goal of addressing a significant public health challenge. This initiative is part of the Health Innovation 2030 Plan and is based